The impact of a mainstream genetic testing pathway and socioeconomic factors on the uptake of germline genetic testing in breast cancer patients: results of the nationwide GENE-SMA... by Chiem Leonardo de Jong, Sabine Siesling, Ghita Carola Wilhelmina Maria Puts, Agnes Jager, Margreet Geertruda Elia Maria Ausems

Get full text

Working toward Personalized Intervention Advice: A Survey Study on Preference Heterogeneity in Patients with Breast Cancer–Related Fatigue by Lian Beenhakker, Kim A. E. Wijlens, Christina Bode, Miriam M. R. Vollenbroek-Hutten, Sabine Siesling, Janine A. van Til, Annemieke Witteveen

Get full text

Surgical treatment after neoadjuvant systemic therapy for HER2-positive invasive breast cancer in the Netherlands: 10-Year trends and the influence an accompanying DCIS component by Roxanne A.W. Ploumen, Thiemo J.A. van Nijnatten, Loes F.S. Kooreman, Adri C. Voogd, Kristien B.M.I. Keymeulen, Sabine Siesling, Marjolein L. Smidt

Get full text

The effect of neoadjuvant chemotherapy on ductal carcinoma in situ in triple-negative breast cancer patients: A nationwide analysis by Eva L. Claassens, Roxanne A.W. Ploumen, Loes F.S. Kooreman, Maartje A.C.E. van Kats, Sabine Siesling, Thiemo J.A. van Nijnatten, Marjolein L. Smidt

Get full text

Corrigendum to ‘Adverse health effects after breast cancer up to 14 years after diagnosis’ [The Breast 61 (2022) 22–28] by Marianne J. Heins, Kelly M. de Ligt, Janneke Verloop, Sabine Siesling, Joke C. Korevaar, Annette Berendsen, Daan Brandenbarg, Anneriet Dassen, Agnes Jager, Jacqueline Hugtenburg, Gerda van der Weele

Get full text

Five-year conditional relative survival up to 10 years post-diagnosis among adolescent and young adult breast cancer patients by age, stage, and receptor subtype by Noëlle J.M.C. Vrancken Peeters, Daniël J. van der Meer, Marleen Kok, Marissa C. van Maaren, Marie-Jeanne T.F.D. Vrancken Peeters, Sabine Siesling, Winette T.A. van der Graaf, Olga Husson

Get full text

Outcome of Endometrial Cancer Stage IIIA with Adnexa or Serosal Involvement Only by Jan J. Jobsen, Lambert Naudin ten Cate, Marnix L. M. Lybeert, Astrid Scholten, Elzbieta M. van der Steen-Banasik, Job van der Palen, Marika C. Stenfert Kroese, Annerie Slot, Eltjo M. J. Schutter, Sabine Siesling

Get full text

The INFLUENCE 3.0 model: Updated predictions of locoregional recurrence and contralateral breast cancer, now also suitable for patients treated with neoadjuvant systemic therapy by M.C. Van Maaren, T.A. Hueting, D.J.P. van Uden, M. van Hezewijk, L. de Munck, M.A.M. Mureau, P.A. Seegers, Q.J.M. Voorham, M.K. Schmidt, G.S. Sonke, C.G.M. Groothuis-Oudshoorn, S. Siesling

Get full text

Implementation of ultra-hypofractionated radiotherapy for breast cancer in the Netherlands in 2020–2023, using registry data and questionnaires by Anouk H. Eijkelboom, Eva J. A. van Beek, Marcel R. Stam, Paulien Westhoff, Marissa C. van Maaren, Margriet G. A. Sattler, Enja J. Bantema-Joppe, Marcel Verheij, Desirée H. J. G. van den Bongard, Sabine Siesling, on behalf of the NABON-COVID-19 Consortium and the COVID and Cancer-NL Consortium

Get full text

Metastatic recurrence in women diagnosed with non-metastatic breast cancer: a systematic review and meta-analysis by Eileen Morgan, Colette O’Neill, Richa Shah, Oliver Langselius, Yaqi Su, Clara Frick, Hanna Fink, Aude Bardot, Paul M. Walsh, Ryan R. Woods, Lou Gonsalves, Jan F. Nygård, Serban Negoita, Esmeralda Ramirez-Pena, Karen Gelmon, Nicoleta Antone, Miriam Mutebi, Sabine Siesling, Fatima Cardoso, Julie Gralow, Isabelle Soerjomataram, Melina Arnold

Get full text